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Abstract: 
A 26 year old lady, her first pregnancy complicated by abruptio placentae at term without obvious cause, 
outcome was fresh stillbirth. In her second pregnancy, she developed severe headache at seven weeks 
gestation, confusion, apathy, dementia, fits and left lower limb swelling within a period less than 10 days. 
Magnetic resonance imaging (MRI) revealed bilateral sinus thrombosis. Low molecular weight heparin 
(Innohep) was started immediately and gradually increased adjusted by (PTT). The patient gradually 
improved and discharged on Innohep. In spite of, injectable anticoagulant therapy, she developed 
intrauterine fetal death at seven month.  
She delivered spontaneously. The first result of screening for antiphospholipid antibodies was positive with 
low protein S. She was diagnosed as probable catastorophic antiphospholipid syndrome (APS). She was 
discharged on oral anticoagulant (warfarin) with adjusted dose according to PT & INR. After a year of 
warfarin therapy, with laboratory follow-up, the second result of screening antiphospholipid antibodies 
remained positive with lower protein S., compared with the first result and; drop in protein C, which 
increases the incidence of thrombosis and makes further pregnancy unadvisable. 
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Introduction:  
Antiphospholipid syndrome was known as autoimmune condition in the mid-fifties in the last century with 
its strong bond with specific autoimmune antibodies (Lupus anticoagulant and anticardiolipin) and classical 
clinical picture (thrombosis, thrombocytopenia and pregnancy loss) (1)  
Doors were opened widely for researches and studies to find out the etiological factors, pathological 
mechanism, genetic inheritance, epidemiology, and effects on other body systems, optimal means of 
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Fig (1) 
Fig (2) 
Source: J. Thromb.Haemostas, 2006; 4:295-306 Source 11th international Congress on Antibodies Sydney, Australia 
Nov. 2004.  
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The European forums worked out new methods of investigation and clarified classical, unusual and silent 
manifestations, including the catastrophic form of the syndrome (Fig. 1). The international congress on 
antiphosophliplid antibodies in Sydney, Australia 2004 updated the classification of the syndrome, and 
revised the criteria to diagnose the syndrome (Fig. 2) including its catastrophic form, and highlighted the 
issues, that remained obscure. 
Case Report: 
The patient was 26 year old Sudanese lady. She has two stillbirths, miscarriage. Her weight was 63Kg, 
height is 167cm, and blood group is (A+). Regarding gynaecological, past medical history, chronic diseases 
and congenital are not detected in the family. No consanguinity with her husband. The first pregnancy 
passed without complications, till term. She was on regular antenatal care visits. She developed spontaneous 
uterine contractions at term, she was hospitalized, routine investigations and examinations were performed. 
Labour was accelerated with oxytotcin, when she was at the end of the first stage of labour, the fetal heart 
sound couldn’t be heard. However, acceleration was continued, the outcome was fresh stillbirth. The 
diagnosis was placental separation.  
 Fourth months later, the patient developed headache on and off mainly on the right side, two days more 
the headache became severe and persistent, she received treatment for malaria, enteric fever and antiviral 
(acyclovir).  
The condition day by day deteriorated by developing confusion, apathy, dementia, loss of concentration, 
and disorientation in place, time, and surroundings, eventually, she developed epileptic seizures. There was 
swelling in the left calf muscle indicating evidence of (DVT). Accidentally the urine for pregnancy test was 
discovered to be positive.   
The patient was transferred to Khartoum (capital of the Sudan) for further investigations, and management. 
(MRI), revealed intracranial sinus thrombosis. Basic investigations were requested, including coagulation 
profile. Low Molecular Heparin (Innohep) was started immediately. The dose increased gradually 
according to INR to reach 16 thousands per day. She also received dexamethasazone, carbomazipine and 
beclomethazone inhaler. The patient started to improve gradually. Ultrasound scanning showed 8 week 
gestation.  
While she was on antenatal care visit, in her seven month’ gestation ultrasound revealed Intrauterine Fetal 
Death (IUFD) in spite of taking Innohep with the same dose 16000 IU/ day since she was discharged. The 
cause most likely due to placental thrombosis and severe placental insufficiency. Fortunately she delivered 
spontaneously. She was screened for thormbophilia as well as antiphospholipid antibodies. The last two 
investigations were done in Germany.  All laboratory findings regarding system and organs were normal. 
She was shifted to 9 mg of Warfarin daily. The result of screening for thromophilia and antiphosphilipid 
antibodies was received and confirmed the presence of antiphospholipid antibodies, and a decrease in 
protein S. 
After more than one year on warfarin 9mg daily, the patient went to Khartoum for follow-up, carrying in 
her mind two substantial questions that concerned her for the whole last year. The first question is for how 
long she will be on medication? The second what is the future of her reproductive life as she now aged 27 
years old?   
Prognosis and Outcome: 
The mortality of the condition is high despite therapy. Mortality is of the order of 50%. In a recent analysis 
of the CAP Registry focusing on mortality (2), the major cause of death was identified in 81/114(71.1%) 
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patients. However, once patients with catastrophic APS have recovered they usually have stable course 
with continued anticoagulation. (3)    
Discussion: 
Further pregnancy is not without hazards and might seriously endanger the patient’s life. The site, the 
mechanism of thrombosis, and the aetiology still are unknown so that no body should take the risk to advice 
pregnancy, it should be avoided by contraception that does not contain estrogens. Barrier and intrauterine 
device are advisable methods of contraception. 
The new thrombophilia screening result done on 15-9-2009 could give an answer to these questions. The 
result shows significant decrease in protein S in comparison with the first result in addition to a protein C 
drop which was normal. The decrease in protein S can be attributed to the prolonged medication with 
warfarin (4) but the drop in protein C can be explained by other factors. The net result is increased incidence 
of thrombosis indicating that further pregnancy is unadvisable.  
Both the patient, and her husband were counselled for surrogation, that encountered by moral and religious 
teaching of Islam, in addition to the culture of the eastern societies, however in some societies this method 
is acceptable. Adoption is acceptable from an Islamic point of view. 
 
Conclusion 
Multidisciplinary approach is important in such conditions. No empirical treatment for pregnant ladies. 
Clinics, including obstetrician, haematologist, and neurologist and specialized centre are crucial for 
decision-making, in such cases. 
So in conclusion the lady experienced episodes of vessels occlusion (DVT), intracranial thrombosis and the 
third event resulted in IUFD due to the placental thrombosis, however, we can't be sure when she developed 
IUFD which could have happened immediately after she went back home, therefore, we think that, it is a 
probable catastrophic antiphospholipid syndrome with low protein S, although protein S is normally low in 
pregnancy.     
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